Task: Answer the multiple choice question.
Query: Which compound exhibits a -4.242% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1cc2n(n1)C(c1cn(-c3ccccc3)nc1C)Nc1ccccc1-2
b: COc1ccc(-c2cc(CCCC(=O)NCCc3ccc(OC)cc3OC)no2)cc1
c: CC(C)CCc1noc(CN2CCN(CC(=O)NC(C)C)CC2)n1
Answer: c. CC(C)CCc1noc(CN2CCN(CC(=O)NC(C)C)CC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CCc1noc(CN2CCN(CC(=O)NC(C)C)CC2)n1
CC(C)CCc1noc(CN2CCN(CC(=O)NC(C)C)CC2)n1
2-[4-[[3-(3-methylbutyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-N-propan-2-ylacetamide